153 related articles for article (PubMed ID: 35714703)
1. CRISPR/Cas9-mediated knockout of Lcn2 in human breast cancer cell line MDA-MB-231 ameliorates erastin-mediated ferroptosis and increases cisplatin vulnerability.
Valashedi MR; Roushandeh AM; Tomita K; Kuwahara Y; Pourmohammadi-Bejarpasi Z; Kozani PS; Sato T; Roudkenar MH
Life Sci; 2022 Sep; 304():120704. PubMed ID: 35714703
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated knockout of Lcn2 effectively enhanced CDDP-induced apoptosis and reduced cell migration capacity of PC3 cells.
Rahimi S; Roushandeh AM; Ebrahimi A; Samadani AA; Kuwahara Y; Roudkenar MH
Life Sci; 2019 Aug; 231():116586. PubMed ID: 31220528
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting LCN2 can suppress the development of NSCLC by promoting ferroptosis.
Pan Z; Li B; Lu P; Rong G; Wang X
Gene; 2024 Feb; 894():148026. PubMed ID: 38000702
[TBL] [Abstract][Full Text] [Related]
4. HNRNPA2B1-mediated m6A modification of FOXM1 promotes drug resistance and inhibits ferroptosis in endometrial cancer via regulation of LCN2.
Jiang J; Zhu J; Qiu P; Ni J; Zhu W; Wang X
Funct Integr Genomics; 2023 Dec; 24(1):3. PubMed ID: 38091112
[TBL] [Abstract][Full Text] [Related]
5. NUPR1 is a critical repressor of ferroptosis.
Liu J; Song X; Kuang F; Zhang Q; Xie Y; Kang R; Kroemer G; Tang D
Nat Commun; 2021 Jan; 12(1):647. PubMed ID: 33510144
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9-mediated knockout of HO-1 decreased the proliferation and migration of T47D cells and increased cisplatin-induced apoptosis: an in vitro study.
Evazi Bakhshi S; Mohammadi Roushandeh A; Habibi Roudkenar M; Shekarchi S; Bahadori MH
Med Oncol; 2022 Aug; 39(11):175. PubMed ID: 35972707
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of Erastin-Induced Ferroptosis in MDA-MB-231 Human Breast Cancer Cells: Evidence for a Critical Role of Protein Disulfide Isomerase.
Wang H; Wang P; Zhu BT
Mol Cell Biol; 2022 Jun; 42(6):e0052221. PubMed ID: 35499331
[TBL] [Abstract][Full Text] [Related]
8. Cucurbitacin B and erastin co-treatment synergistically induced ferroptosis in breast cancer cells via altered iron-regulating proteins and lipid peroxidation.
Bakar-Ates F; Ozkan E
Toxicol In Vitro; 2024 Feb; 94():105732. PubMed ID: 37956772
[TBL] [Abstract][Full Text] [Related]
9. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
Javadi M; Sazegar H; Doosti A
BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
[TBL] [Abstract][Full Text] [Related]
10. Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3.
Schröder SK; Pinoé-Schmidt M; Weiskirchen R
Cells; 2022 Jan; 11(2):. PubMed ID: 35053376
[TBL] [Abstract][Full Text] [Related]
11. VDR activation attenuate cisplatin induced AKI by inhibiting ferroptosis.
Hu Z; Zhang H; Yi B; Yang S; Liu J; Hu J; Wang J; Cao K; Zhang W
Cell Death Dis; 2020 Jan; 11(1):73. PubMed ID: 31996668
[TBL] [Abstract][Full Text] [Related]
12. G-4 inhibits triple negative breast cancer by inducing cell apoptosis and promoting LCN2-dependent ferroptosis.
Sun G; Wang J; Liu F; Zhao C; Cui S; Wang Z; Liu Z; Zhang Q; Xiang C; Zhang Y; Galons H; Yu P; Teng Y
Biochem Pharmacol; 2024 Apr; 222():116077. PubMed ID: 38395264
[TBL] [Abstract][Full Text] [Related]
13. Melittin inhibits tumor cell migration and enhances cisplatin sensitivity by suppressing IL-17 signaling pathway gene LCN2 in castration-resistant prostate cancer.
Yan R; Dai W; Mao Y; Yu G; Li W; Shu M; Xu B
Prostate; 2023 Nov; 83(15):1430-1445. PubMed ID: 37517867
[TBL] [Abstract][Full Text] [Related]
14. HMOX1 Promotes Ferroptosis Induced by Erastin in Lens Epithelial Cell through Modulates Fe
Liao S; Huang M; Liao Y; Yuan C
Curr Eye Res; 2023 Jan; 48(1):25-33. PubMed ID: 36300537
[TBL] [Abstract][Full Text] [Related]
15. Erastin synergizes with cisplatin via ferroptosis to inhibit ovarian cancer growth in vitro and in vivo.
Cheng Q; Bao L; Li M; Chang K; Yi X
J Obstet Gynaecol Res; 2021 Jul; 47(7):2481-2491. PubMed ID: 33882617
[TBL] [Abstract][Full Text] [Related]
16. Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells.
Yu M; Gai C; Li Z; Ding D; Zheng J; Zhang W; Lv S; Li W
Cancer Sci; 2019 Oct; 110(10):3173-3182. PubMed ID: 31464035
[TBL] [Abstract][Full Text] [Related]
17. Regulation of GSK3β/Nrf2 signaling pathway modulated erastin-induced ferroptosis in breast cancer.
Wu X; Liu C; Li Z; Gai C; Ding D; Chen W; Hao F; Li W
Mol Cell Biochem; 2020 Oct; 473(1-2):217-228. PubMed ID: 32642794
[TBL] [Abstract][Full Text] [Related]
18. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer.
Zhang Z; Lu M; Chen C; Tong X; Li Y; Yang K; Lv H; Xu J; Qin L
Theranostics; 2021; 11(7):3167-3182. PubMed ID: 33537080
[No Abstract] [Full Text] [Related]
19. Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells.
Ozkan E; Bakar-Ates F
Life Sci; 2023 Jan; 312():121222. PubMed ID: 36442526
[TBL] [Abstract][Full Text] [Related]
20. BID links ferroptosis to mitochondrial cell death pathways.
Neitemeier S; Jelinek A; Laino V; Hoffmann L; Eisenbach I; Eying R; Ganjam GK; Dolga AM; Oppermann S; Culmsee C
Redox Biol; 2017 Aug; 12():558-570. PubMed ID: 28384611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
